Cargando…

Role of autoantibodies and blood–brain barrier leakage in cognitive impairment in systemic lupus erythematosus

OBJECTIVE: Cognitive impairment is common in patients with SLE but the cause is unknown. The current cross-sectional study examined the association between select SLE-related autoantibodies, other serological biomarkers and extensive blood–brain barrier (BBB) leakage in patients with SLE with and wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hanly, John G, Legge, Alexandra, Kamintsky, Lyna, Friedman, Alon, Hashmi, Javeria A, Beyea, Steven D, Fisk, John, Omisade, Antonina, Calkin, Cynthia, Bardouille, Tim, Bowen, Chris, Matheson, Kara, Fritzler, Marvin J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Immunology and Inflammation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204449/ https://www.ncbi.nlm.nih.gov/pubmed/35705307 http://dx.doi.org/10.1136/lupus-2022-000668

Ejemplares similares

Symptoms reported by Canadians posted in Havana are linked with reduced white matter fibre density
por: Aristi, Guillermo, et al.
Publicado: (2022)

Blood-brain barrier imaging as a potential biomarker for bipolar disorder progression
por: Kamintsky, Lyna, et al.
Publicado: (2019)

Insulin Resistance and Blood-Brain Barrier Dysfunction Underlie Neuroprogression in Bipolar Disorder
por: Calkin, Cynthia, et al.
Publicado: (2021)

Significance of Autoantibodies to Ki/SL as Biomarkers for Systemic Lupus Erythematosus and Sicca Syndrome
por: Mahler, Michael, et al.
Publicado: (2022)

Physical activity and sedentary behavior in patients with systemic lupus erythematosus and rheumatoid arthritis
por: Legge, Alexandra, et al.
Publicado: (2017)

Belatacept in kidney transplant patients with systemic lupus erythematosus
por: Carrión-Barberà, Irene, et al.
Publicado: (2019)

Intermuscular adipose tissue in patients with systemic lupus erythematosus
por: Gamboa, Jorge Luis, et al.
Publicado: (2022)

9.4 Autoantibodies in pediatric systemic lupus erythematosus: ethnic grouping, autoantibody clustering and clinical correlations
por: Jurencak, R, et al.
Publicado: (2008)

Autoantibodies in Systemic Sclerosis: Unanswered Questions
por: Kayser, Cristiane, et al.
Publicado: (2015)

Clinical features which predict neuronal surface autoantibodies in new-onset focal epilepsy: implications for immunotherapies
por: McGinty, Ronan N, et al.
Publicado: (2021)

Soluble Fas ligand drives autoantibody-induced arthritis by binding to DR5/TRAIL-R2
por: Jeong, Dongjin, et al.
Publicado: (2021)

Distinct impact of IgG subclass on autoantibody pathogenicity in different IgG4-mediated diseases
por: Bi, Yanxia, et al.
Publicado: (2022)

Autoantibody discovery across monogenic, acquired, and COVID-19-associated autoimmunity with scalable PhIP-seq
por: Vazquez, Sara E, et al.
Publicado: (2022)

Maternal autoantibody profiles at risk for autoimmune congenital heart block: a prospective study in high-risk patients
por: Tonello, Marta, et al.
Publicado: (2016)

Brain MRI in patients with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus
por: Arinuma, Yoshiyuki, et al.
Publicado: (2014)

Neutrophil and lymphocyte counts are associated with different immunopathological mechanisms in systemic lupus erythematosus
por: Han, Bobby Kwanghoon, et al.
Publicado: (2020)

Intra-individual variability in information processing speed reflects white matter microstructure in multiple sclerosis()
por: Mazerolle, Erin L., et al.
Publicado: (2013)

Reduced response to Epstein–Barr virus antigens by T-cells in systemic lupus erythematosus patients
por: Draborg, Anette Holck, et al.
Publicado: (2014)

Association between systemic lupus erythematosus and disruption of gut microbiota: a meta-analysis
por: Xiang, Shate, et al.
Publicado: (2022)

The use and abuse of commercial kits used to detect autoantibodies
por: Fritzler, Marvin J, et al.
Publicado: (2003)

Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus
por: Fasano, Serena, et al.
Publicado: (2023)

High-dimensional analysis of T-cell profiling variations following belimumab treatment in systemic lupus erythematosus
por: Maeda, Shinji, et al.
Publicado: (2023)

Toward a new autoantibody diagnostic orthodoxy: understanding the bad, good and indifferent
por: Fritzler, Marvin J.
Publicado: (2012)

Increased alloreactive and autoreactive antihuman leucocyte antigen antibodies associated with systemic lupus erythematosus and rheumatoid arthritis
por: Jackman, Rachael P, et al.
Publicado: (2018)

Effects of targeting the transcription factors Ikaros and Aiolos on B cell activation and differentiation in systemic lupus erythematosus
por: Rivellese, Felice, et al.
Publicado: (2021)

Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks
por: Neupane, Binod, et al.
Publicado: (2023)

Visual and Auditory fMRI Paradigms for Presurgical Language Mapping: Convergent Validity and Relationship to Individual Variables
por: Omisade, Antonina, et al.
Publicado: (2019)

The changing landscape of the clinical value of the PM/Scl autoantibody system
por: Mahler, Michael, et al.
Publicado: (2009)

Ultrasound detects subclinical joint inflammation in the hands and wrists of patients with systemic lupus erythematosus without musculoskeletal symptoms
por: Ruano, Carina A, et al.
Publicado: (2017)

Autoantibodies in Systemic Autoimmune Disorders
por: Mahler, Michael, et al.
Publicado: (2014)

The opportunity and imperative for point-of-care diagnostics in systemic lupus erythematosus
por: Fritzler, Marvin J
Publicado: (2014)

Detection of autoantibodies using chemiluminescence technologies
por: Mahler, Michael, et al.
Publicado: (2016)

The Spectrum of Anti-Chromatin/Nucleosome Autoantibodies: Independent and Interdependent Biomarkers of Disease
por: Mehra, Sonal, et al.
Publicado: (2014)

Increased von Willebrand factor levels in patients with systemic lupus erythematosus reflect inflammation rather than increased propensity for platelet activation
por: Nossent, Johannes C, et al.
Publicado: (2016)

Iberdomide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled, ascending-dose, phase 2a study
por: Furie, Richard A, et al.
Publicado: (2022)

Combining C reactive protein and serum albumin to predict 90-day mortality in systemic lupus erythematosus with serious community-acquired infections
por: He, Shuangjun, et al.
Publicado: (2021)

Progress in understanding the diagnostic and pathogenic role of autoantibodies associated with systemic sclerosis
por: Choi, May Y., et al.
Publicado: (2016)

Emerging technologies in autoantibody testing for rheumatic diseases
por: Olsen, Nancy J., et al.
Publicado: (2017)

Update on autoantibodies and related biomarkers in autoimmune inflammatory myopathies
por: Choi, May Y., et al.
Publicado: (2023)

The Utilization of Autoantibodies in Approaches to Precision Health
por: Fritzler, Marvin J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_d27hvgc2sbvvq2a9s5usfd8g4j